TABLE 2. Resistance of gonococcal isolates to ciprofloxacin, penicillin, tetracycline, azithromycin, cefixime, ceftriaxone, and spectinomycin — 13 Gonococcal Resistance Surveillance Program sentinel sites,* China, 2022.
| Province | Antibiotic/MIC, no. of resistant isolates (%) |
||||||
|---|---|---|---|---|---|---|---|
| Ciprofloxacin/>0.06 mg/L† | Penicillin/>1 mg/L† | Tetracycline/>1 mg/L† | Azithromycin/>0.5 mg/L† | Cefixime/>0.125 mg/L† | Ceftriaxone/>0.125 mg/L† | Spectinomycin/>64 mg/L† | |
| Chongqing |
64 (97.0) |
43 (65.2) |
28 (42.4) |
14 (21.2) |
16 (24.2) |
9 (13.6) |
0 (—) |
| Guangdong |
741 (98.7) |
604 (80.4) |
509 (67.8) |
161 (21.4) |
172 (22.9) |
66 (8.8) |
0 (—) |
| Guangxi |
714 (99.3) |
538 (74.8) |
631 (87.8) |
115 (16.0) |
65 (9.0) |
45 (7.6) |
1 (0.1) |
| Hainan |
53 (93.0) |
19 (33.3) |
25 (43.9) |
2 (3.5) |
1 (1.8) |
1 (1.8) |
0 (—) |
| Hunan |
66 (100.0) |
59 (89.4) |
26 (39.4) |
25 (38.0) |
10 (15.2) |
2 (3.0) |
0 (—) |
| Jiangsu |
209 (84.3) |
184 (74.2) |
197 (79.4) |
32 (12.9) |
55 (28.2) |
24 (12.3) |
0 (—) |
| Shanghai |
111 (100.0) |
109 (98.2) |
60 (54.1) |
42 (37.8) |
14 (12.6) |
0 (—) |
0 (—) |
| Shanxi |
65 (100.0) |
54 (83.0) |
49 (75.4) |
0 (—) |
6 (9.2) |
4 (6.2) |
0 (—) |
| Sichuan |
120 (100.0) |
86 (71.7) |
101 (84.2) |
11 (9.2) |
44 (36.7) |
30 (25.0) |
0 (—) |
| Tianjin |
53 (100.0) |
47 (88.7) |
15 (28.3) |
12 (22.6) |
19 (35.9) |
14 (26.4) |
0 (—) |
| Xinjiang |
21 (77.8) |
19 (70.4) |
27 (100.0) |
6 (22.2) |
7 (25.9) |
7 (25.9) |
0 (—) |
| Yunnan |
146 (100.0) |
130 (89.0) |
139 (95.2) |
25 (17.1) |
12 (8.2) |
10 (6.9) |
0 (—) |
| Zhejiang |
374 (99.7) |
289 (77.1) |
356 (94.9) |
28 (7.5) |
20 (5.3) |
10 (2.8) |
0 (—) |
| Total | 2,737 (97.6) | 2,181 (77.8) | 2,163 (77.1) | 473 (16.9) | 441 (16.0) | 222 (8.1) | 1 (<1) |
Abbreviation: MIC = minimum inhibitory concentration.
* Data from 13 of 19 provincial sentinel surveillance sites were included in the analysis.
† Concentrations listed are the MIC thresholds used to categorize resistant isolates.